Molecular classification and diagnostics of upper urinary tract urothelial carcinoma

Upper urinary tract urothelial carcinoma (UTUC) is one of the common urothelial cancers. Its molecular pathogenesis, however, is poorly understood, with no useful biomarkers available for accurate diagnosis and molecular classification. Through an integrated genetic study involving 199 UTUC samples, we delineate the landscape of genetic alterations in UTUC enabling genetic/molecular classification. According to the mutational status of TP53, MDM2, RAS, and FGFR3, UTUC is classified into five subtypes having discrete profiles of gene expression, tumor location/histology, and clinical outcome, which is largely recapitulated in an independent UTUC cohort. Sequencing of urine sediment-derived DNA has a high diagnostic value for UTUC with 82.2% sensitivity and 100% specificity. These results provide a solid basis for better diagnosis and management of UTUC.

Automated summary

Through an integrated genetic study involving 199 UTUC samples, the landscape of genetic alterations in UTUC was delineated, enabling genetic/molecular classification. UTUC is classified into five subtypes based on the mutational status of TP53, MDM2, RAS, and FGFR3, with discrete profiles of gene expression, tumor location/histology, and clinical outcome. Sequencing of urine sediment-derived DNA has high diagnostic value for UTUC with 82.2% sensitivity and 100% specificity, providing a solid basis for better diagnosis and management of UTUC.